4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-15-043893
CIK 0001328143operating
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:22 PM ET
Size
10.8 KB
Accession
0001209191-15-043893
Insider Transaction Report
Form 4
BOOTH RICHARD H
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-05-14+19,000→ 19,000 totalExercise: $17.97Exp: 2025-05-13→ Common Stock (19,000 underlying) - Sale
Common Stock
2015-05-15$17.85/sh−1,000$17,850→ 46,778 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from May 14, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 5:22 PM ET
- Size
- 10.8 KB